| Literature DB >> 25829089 |
Abstract
The performance of fludeoxyglucose F 18 (FDG)-PET/computed tomography (CT) in the initial and follow-up evaluation of patients with melanoma is well established. Groups are beginning to investigate whether the inclusion of FDG-PET/CT into a staging or surveillance algorithm results in an improvement in patient outcome and whether such an imaging program would be cost-effective.Entities:
Keywords: Melanoma; Outcomes; PET/CT; Surveillance
Mesh：
Substances：
Year: 2015 PMID： 25829089 DOI： 10.1016/j.cpet.2014.12.006
Source DB: PubMed Journal: PET Clin ISSN： 1556-8598